Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015

Documenti analoghi

• Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events
  di: Sasaoka, Sayaka, et al.
  Pubblicazione: (2016)
• Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases
  di: Hatahira, Haruna, et al.
  Pubblicazione: (2017)
• Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
  di: Hasegawa, Shiori, et al.
  Pubblicazione: (2017)
• Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database
  di: Abe, Junko, et al.
  Pubblicazione: (2016)
• Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004−2016
  di: Motooka, Yumi, et al.
  Pubblicazione: (2018)